Published in J Virol on February 01, 1998
Epitope-specific evolution of human CD8(+) T cell responses from primary to persistent phases of Epstein-Barr virus infection. J Exp Med (2002) 2.89
Inhibition of MHC class I-restricted antigen presentation by gamma 2-herpesviruses. Proc Natl Acad Sci U S A (2000) 2.38
Rta of murine gammaherpesvirus 68 reactivates the complete lytic cycle from latency. J Virol (2000) 2.35
Transcription program of murine gammaherpesvirus 68. J Virol (2003) 1.96
Dissecting the host response to a gamma-herpesvirus. Philos Trans R Soc Lond B Biol Sci (2001) 1.89
Identification of the in vivo role of a viral bcl-2. J Exp Med (2002) 1.88
Virus-specific CD8(+) T cell numbers are maintained during gamma-herpesvirus reactivation in CD4-deficient mice. Proc Natl Acad Sci U S A (1998) 1.73
Non-antigen-specific B-cell activation following murine gammaherpesvirus infection is CD4 independent in vitro but CD4 dependent in vivo. J Virol (1999) 1.71
Function of Rta is essential for lytic replication of murine gammaherpesvirus 68. J Virol (2001) 1.61
Antibody to a lytic cycle viral protein decreases gammaherpesvirus latency in B-cell-deficient mice. J Virol (2002) 1.48
Gammaherpesvirus persistence alters key CD8 T-cell memory characteristics and enhances antiviral protection. J Virol (2006) 1.36
Alpha/beta interferons regulate murine gammaherpesvirus latent gene expression and reactivation from latency. J Virol (2005) 1.35
Postexposure vaccination massively increases the prevalence of gamma-herpesvirus-specific CD8+ T cells but confers minimal survival advantage on CD4-deficient mice. Proc Natl Acad Sci U S A (2000) 1.34
Murine gammaherpesvirus-68 glycoprotein B presents a difficult neutralization target to monoclonal antibodies derived from infected mice. J Gen Virol (2006) 1.26
ORF18 is a transfactor that is essential for late gene transcription of a gammaherpesvirus. J Virol (2006) 1.24
In vivo imaging of murid herpesvirus-4 infection. J Gen Virol (2009) 1.21
IgG fc receptors provide an alternative infection route for murine gamma-herpesvirus-68. PLoS One (2007) 1.19
Identification of cis sequences required for lytic DNA replication and packaging of murine gammaherpesvirus 68. J Virol (2004) 1.13
Disruption of CCL21-induced chemotaxis in vitro and in vivo by M3, a chemokine-binding protein encoded by murine gammaherpesvirus 68. J Virol (2003) 1.10
The murine gammaherpesvirus-68 gp150 acts as an immunogenic decoy to limit virion neutralization. PLoS One (2007) 1.10
Two kinetic patterns of epitope-specific CD8 T-cell responses following murine gammaherpesvirus 68 infection. J Virol (2010) 1.08
Antibody-independent control of gamma-herpesvirus latency via B cell induction of anti-viral T cell responses. PLoS Pathog (2006) 1.08
Elevated chemokine responses are maintained in lungs after clearance of viral infection. J Virol (2002) 1.07
Role for MyD88 signaling in murine gammaherpesvirus 68 latency. J Virol (2008) 1.05
Lymphotoxin-alpha-deficient mice can clear a productive infection with murine gammaherpesvirus 68 but fail to develop splenomegaly or lymphocytosis. J Virol (2000) 1.03
Antibody evasion by the N terminus of murid herpesvirus-4 glycoprotein B. EMBO J (2007) 1.00
Pathogenesis of a model gammaherpesvirus in a natural host. J Virol (2010) 0.99
Regression of a murine gammaherpesvirus 68-positive b-cell lymphoma mediated by CD4 T lymphocytes. J Virol (2001) 0.98
Post-exposure vaccination improves gammaherpesvirus neutralization. PLoS One (2007) 0.96
Blimp-1-dependent plasma cell differentiation is required for efficient maintenance of murine gammaherpesvirus latency and antiviral antibody responses. J Virol (2009) 0.95
Human herpesvirus 8 infections in the Amsterdam Cohort Studies (1984-1997): analysis of seroconversions to ORF65 and ORF73. Proc Natl Acad Sci U S A (2000) 0.94
CD28(-/-) mice show defects in cellular and humoral immunity but are able to control infection with murine gammaherpesvirus 68. J Virol (2002) 0.93
Effective control of chronic gamma-herpesvirus infection by unconventional MHC Class Ia-independent CD8 T cells. PLoS Pathog (2006) 0.91
Murine gammaherpesvirus 68 infection protects lupus-prone mice from the development of autoimmunity. Proc Natl Acad Sci U S A (2012) 0.91
Protein kinase C theta is not essential for T-cell-mediated clearance of murine gammaherpesvirus 68. J Virol (2005) 0.91
Important role for the murid herpesvirus 4 ribonucleotide reductase large subunit in host colonization via the respiratory tract. J Virol (2010) 0.89
Tpl2/AP-1 enhances murine gammaherpesvirus 68 lytic replication. J Virol (2009) 0.86
Differential requirement for CD28 and CD80/86 pathways of costimulation in the long-term control of murine gammaherpesvirus-68. Virology (2006) 0.85
The de novo methyltransferases DNMT3a and DNMT3b target the murine gammaherpesvirus immediate-early gene 50 promoter during establishment of latency. J Virol (2010) 0.83
Antibody limits in vivo murid herpesvirus-4 replication by IgG Fc receptor-dependent functions. J Gen Virol (2009) 0.83
Retention of anergy and inhibition of antibody responses during acute γ herpesvirus 68 infection. J Immunol (2012) 0.83
Prospects of a novel vaccination strategy for human gamma-herpesviruses. Immunol Res (2010) 0.82
Murine gammaherpesvirus 68 glycoprotein 150 does not contribute to latency amplification in vivo. Virol J (2012) 0.80
Differential impact of ageing on cellular and humoral immunity to a persistent murine gamma-herpesvirus. Immun Ageing (2010) 0.80
Virion endocytosis is a major target for murid herpesvirus-4 neutralization. J Gen Virol (2012) 0.80
Interplay of Murine Gammaherpesvirus 68 with NF-kappaB Signaling of the Host. Front Microbiol (2016) 0.78
Enhanced response of T cells from murine gammaherpesvirus 68-infected mice lacking the suppressor of T cell receptor signaling molecules Sts-1 and Sts-2. PLoS One (2014) 0.78
Impaired B cell function during viral infections due to PTEN-mediated inhibition of the PI3K pathway. J Exp Med (2017) 0.77
KSHV targeted therapy: an update on inhibitors of viral lytic replication. Viruses (2014) 0.77
Type I Interferons and NK Cells Restrict Gammaherpesvirus Lymph Node Infection. J Virol (2016) 0.77
B cell response to herpesvirus infection of the olfactory neuroepithelium. J Virol (2014) 0.77
Importance of antibody in virus infection and vaccine-mediated protection by a latency-deficient recombinant murine γ-herpesvirus-68. J Immunol (2011) 0.77
Type 1 interferon signalling to dendritic cells limits Murid Herpesvirus-4 spread from the olfactory epithelium. J Virol (2017) 0.75
The major envelope glycoprotein of Murid Herpesvirus-4 promotes sexual transmission. J Virol (2017) 0.75
Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science (1994) 39.60
Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature (1994) 11.22
Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature (1993) 9.81
The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell (1996) 8.25
Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science (1996) 7.00
Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells. J Exp Med (1996) 6.08
Herpes simplex virus turns off the TAP to evade host immunity. Nature (1995) 5.93
Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature (1994) 5.58
Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo. J Gen Virol (1992) 5.42
Cellular events in the lymph node and lung of mice with influenza. Consequences of depleting CD4+ T cells. J Immunol (1990) 4.83
Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu Rev Immunol (1997) 4.65
Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature (1995) 4.53
Mature B cells are required for acute splenic infection, but not for establishment of latency, by murine gammaherpesvirus 68. J Virol (1996) 4.02
Murine herpesvirus 68 is genetically related to the gammaherpesviruses Epstein-Barr virus and herpesvirus saimiri. J Gen Virol (1990) 3.41
Cloning and molecular characterization of the murine herpesvirus 68 genome. J Gen Virol (1990) 3.33
Pathogenesis of murine gammaherpesvirus infection in mice deficient in CD4 and CD8 T cells. J Virol (1993) 2.93
Epstein-Barr virus strategy in normal and neoplastic B cells. Cell (1994) 2.63
Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro. Nature (1977) 2.58
Murine gammaherpesvirus 68 encodes tRNA-like sequences which are expressed during latency. J Gen Virol (1997) 2.44
Murine gammaherpesvirus-induced splenomegaly: a critical role for CD4 T cells. J Gen Virol (1996) 2.37
Absence of splenic latency in murine gammaherpesvirus 68-infected B cell-deficient mice. J Gen Virol (1996) 2.25
Temporal loss of the activated L-selectin-low phenotype for virus-specific CD8+ memory T cells. J Immunol (1995) 2.20
Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. J Exp Med (1994) 2.17
Establishment and persistence of virus-specific CD4+ and CD8+ T cell memory. Immunol Rev (1996) 2.11
Different roles for cytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses. Curr Opin Immunol (1996) 2.11
Virus-specific antigen presentation by different subsets of cells from lung and mediastinal lymph node tissues of influenza virus-infected mice. J Virol (1995) 2.10
Interactions of the murine gammaherpesvirus with the immune system. Curr Opin Immunol (1994) 2.09
Concurrent production of interleukin-2, interleukin-10, and gamma interferon in the regional lymph nodes of mice with influenza pneumonia. J Virol (1994) 2.07
Recruitment and proliferation of CD8+ T cells in respiratory virus infections. J Immunol (1995) 2.05
A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface. EMBO J (1997) 1.98
Pathogenesis of an infectious mononucleosis-like disease induced by a murine gamma-herpesvirus: role for a viral superantigen? J Exp Med (1997) 1.88
Cytokine production in the immune response to murine gammaherpesvirus 68. J Virol (1996) 1.61
The HCMV gene products US11 and US2 differ in their ability to attack allelic forms of murine major histocompatibility complex (MHC) class I heavy chains. J Exp Med (1997) 1.51
Gamma interferon is not essential for recovery from acute infection with murine gammaherpesvirus 68. J Virol (1997) 1.38
Bone marrow can function as a lymphoid organ during a primary immune response under conditions of disrupted lymphocyte trafficking. J Immunol (1997) 1.27
AIDS. Viruses, cytokines and Kaposi's sarcoma. Curr Biol (1995) 1.21
Cytotoxic T cells and human herpes virus infections. Curr Top Microbiol Immunol (1994) 1.12
Inflammatory infiltration of the upper airway epithelium during Sendai virus infection: involvement of epithelial dendritic cells. J Virol (1997) 1.12
Defective presentation of MHC class I-restricted cytotoxic T-cell epitopes in Burkitt's lymphoma cells. Int J Cancer (1996) 1.02
Immunological control of murine gammaherpesvirus infection is independent of perforin. J Gen Virol (1997) 0.97
Targeted disruption of the IL-6 related genes: gp130 and NF-IL-6. Immunol Rev (1995) 0.89
Virus-specific cytotoxic T cell-mediated lysis of lymphocytes in vitro and in vivo. J Immunol (1993) 0.88
Functional significance of two cytolytic pathways of cytotoxic T lymphocytes. J Leukoc Biol (1995) 0.79
MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness. Adv Immunol (1979) 15.58
Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature (1974) 13.24
Specificity of virus-immune effector T cells for H-2K or H-2D compatible interactions: implications for H-antigen diversity. Transplant Rev (1976) 8.10
Immunological surveillance against altered self components by sensitised T lymphocytes in lymphocytic choriomeningitis. Nature (1974) 6.99
Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature (1996) 6.17
Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells. J Exp Med (1996) 6.08
Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. Immunity (1998) 5.98
Virus-specific CD8+ T-cell memory determined by clonal burst size. Nature (1994) 5.49
Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature (1996) 5.45
Generation of both cross-reactive and virus-specific T-cell populations after immunization with serologically distinct influenza A viruses. J Exp Med (1977) 5.20
Cellular events in the lymph node and lung of mice with influenza. Consequences of depleting CD4+ T cells. J Immunol (1990) 4.83
T-cell-mediated immunopathology in viral infections. Transplant Rev (1974) 4.72
Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8+ T cells. J Exp Med (1991) 4.49
Genes required for cytotoxicity against virus-infected target cells in K and D regions of H-2 complex. Nature (1975) 4.41
H-2 compatibility is required for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. J Exp Med (1975) 4.16
CD8+ T cells clear influenza virus by perforin or Fas-dependent processes. J Immunol (1997) 4.10
Measuring the diaspora for virus-specific CD8+ T cells. Proc Natl Acad Sci U S A (2001) 3.51
Enhanced immunological surveillance in mice heterozygous at the H-2 gene complex. Nature (1975) 3.49
A biological role for the major histocompatibility antigens. Lancet (1975) 3.40
Delayed clearance of Sendai virus in mice lacking class I MHC-restricted CD8+ T cells. J Immunol (1992) 3.31
Defective lymphoid development in mice lacking Jak3. Science (1995) 3.04
Heterogeneity of the cytotoxic response of thymus-derived lymphocytes after immunization with influenza viruses. Proc Natl Acad Sci U S A (1977) 3.02
A previously unrecognized H-2D(b)-restricted peptide prominent in the primary influenza A virus-specific CD8(+) T-cell response is much less apparent following secondary challenge. J Virol (2000) 2.79
Cytotoxic T-cell responses in mice infected with influenza and vaccinia viruses vary in magnitude with H-2 genotype. J Exp Med (1978) 2.54
Characteristics of the interaction in vitro between cytotoxic thymus-derived lymphocytes and target monolayers infected with lymphocytic choriomeningitis virus. Scand J Immunol (1974) 2.42
Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity (1994) 2.39
Inhibition of MHC class I-restricted antigen presentation by gamma 2-herpesviruses. Proc Natl Acad Sci U S A (2000) 2.38
Influenza virus RNA in the lung and lymphoid tissue of immunologically intact and CD4-depleted mice. J Gen Virol (1991) 2.33
Specificity and development of cytotoxic thymus-derived lymphocytes in lymphocytic choriomeningitis. J Immunol (1974) 2.23
Late dominance of the inflammatory process in murine influenza by gamma/delta + T cells. J Exp Med (1990) 2.21
Temporal loss of the activated L-selectin-low phenotype for virus-specific CD8+ memory T cells. J Immunol (1995) 2.20
Antibody to influenza virus matrix protein detects a common antigen on the surface of cells infected with type A influenza viruses. J Exp Med (1977) 2.16
Diversity of epitope and cytokine profiles for primary and secondary influenza a virus-specific CD8+ T cell responses. J Immunol (2001) 2.14
CD4(+) T cell-mediated control of a gamma-herpesvirus in B cell-deficient mice is mediated by IFN-gamma. Proc Natl Acad Sci U S A (1999) 2.14
Prominent usage of V beta 8.3 T cells in the H-2Db-restricted response to an influenza A virus nucleoprotein epitope. J Immunol (1993) 2.07
Concurrent production of interleukin-2, interleukin-10, and gamma interferon in the regional lymph nodes of mice with influenza pneumonia. J Virol (1994) 2.07
Major transplantation antigens, viruses, and specificity of surveillance T cells. Contemp Top Immunobiol (1977) 2.05
Recruitment and proliferation of CD8+ T cells in respiratory virus infections. J Immunol (1995) 2.05
Characteristics of the influenza virus-specific CD8+ T cell response in mice homozygous for disruption of the H-2lAb gene. J Immunol (1995) 2.01
Changing patterns of dominance in the CD8+ T cell response during acute and persistent murine gamma-herpesvirus infection. Eur J Immunol (1999) 2.00
Activation of cytokine genes in T cells during primary and secondary murine influenza pneumonia. J Exp Med (1993) 1.98
Capacity of sensitized thymus-derived lymphocytes to induce fatal lymphocytic choriomeningitis is restricted by the H-2 gene complex. J Immunol (1975) 1.93
Pathogenesis of an infectious mononucleosis-like disease induced by a murine gamma-herpesvirus: role for a viral superantigen? J Exp Med (1997) 1.88
Clearance of an influenza A virus by CD4+ T cells is inefficient in the absence of B cells. J Virol (1998) 1.87
Diminished primary and secondary influenza virus-specific CD8(+) T-cell responses in CD4-depleted Ig(-/-) mice. J Virol (2000) 1.87
In vivo proliferation of naïve and memory influenza-specific CD8(+) T cells. Proc Natl Acad Sci U S A (1999) 1.87
Forced degradation of Fas inhibits apoptosis in adenovirus-infected cells. Nature (1998) 1.87
The role of antigen in the localization of naive, acutely activated, and memory CD8(+) T cells to the lung during influenza pneumonia. J Immunol (2001) 1.85
Profound protection against respiratory challenge with a lethal H7N7 influenza A virus by increasing the magnitude of CD8(+) T-cell memory. J Virol (2000) 1.85
Specific immune lysis of paramyxovirus-infected cells by H-2-compatible thymus-derived lymphocytes. Immunology (1976) 1.81
Cytotoxic thymus-derived lymphocytes in cerebrospinal fluid of mice with lymphocytic choriomeningitis. J Exp Med (1973) 1.80
A gamma-herpesvirus sneaks through a CD8(+) T cell response primed to a lytic-phase epitope. Proc Natl Acad Sci U S A (1999) 1.78
Inflammatory process in murine lymphocytic choriomeningitis is maximal in H-2K or H-2D compatible interactions. J Immunol (1976) 1.78
The discovery of MHC restriction. Immunol Today (1997) 1.76
Quantitative analysis of the influenza virus-specific CD4+ T cell memory in the absence of B cells and Ig. J Immunol (1996) 1.75
Virus-specific CD8(+) T cell numbers are maintained during gamma-herpesvirus reactivation in CD4-deficient mice. Proc Natl Acad Sci U S A (1998) 1.73
Non-antigen-specific B-cell activation following murine gammaherpesvirus infection is CD4 independent in vitro but CD4 dependent in vivo. J Virol (1999) 1.71
Analysis of the virus-specific and nonspecific B cell response to a persistent B-lymphotropic gammaherpesvirus. J Immunol (2000) 1.64
In vitro evidence of cell-mediated immunity after exposure of mice to both live and inactivated rabies virus. Proc Natl Acad Sci U S A (1977) 1.63
Immunological surveillance of tumors in the context of major histocompatibility complex restriction of T cell function. Adv Cancer Res (1984) 1.62
Cytokine production in the immune response to murine gammaherpesvirus 68. J Virol (1996) 1.61
Protection against a lethal avian influenza A virus in a mammalian system. J Virol (1999) 1.60
Cytokine profiles of bronchoalveolar lavage cells from mice with influenza pneumonia: consequences of CD4+ and CD8+ T cell depletion. Reg Immunol (1993) 1.56
Immunological control of a murine gammaherpesvirus independent of CD8+ T cells. J Gen Virol (1999) 1.49
Vaccinia-specific cytotoxic T-cell responses in the context of H-2 antigens not encountered in thymus may reflect aberrant recognition of a virus-H-2 complex. J Exp Med (1979) 1.48
Contemporary analysis of MHC-related immunodominance hierarchies in the CD8+ T cell response to influenza A viruses. J Immunol (2000) 1.47
Partitioning of responder CD8+ T cells in lymph node and lung of mice with Sendai virus pneumonia by LECAM-1 and CD45RB phenotype. J Immunol (1993) 1.46
Administration of anti-IFN-gamma antibody to beta 2-microglobulin-deficient mice delays influenza virus clearance but does not switch the response to a T helper cell 2 phenotype. J Immunol (1994) 1.43
Immune CD4+ T cells promote the clearance of influenza virus from major histocompatibility complex class II -/- respiratory epithelium. J Virol (1996) 1.42
Requirement for CD40 ligand, CD4(+) T cells, and B cells in an infectious mononucleosis-like syndrome. J Virol (1999) 1.41
Localization of CD4+ T cell epitope hotspots to exposed strands of HIV envelope glycoprotein suggests structural influences on antigen processing. Proc Natl Acad Sci U S A (2001) 1.39
Gamma interferon is not essential for recovery from acute infection with murine gammaherpesvirus 68. J Virol (1997) 1.38
T-cell populations specifically depleted of alloreactive potential cannot be induced to lyse H-2-different virus-infected target cells. J Exp Med (1978) 1.36
Characteristics of virus-specific CD8(+) T cells in the liver during the control and resolution phases of influenza pneumonia. Proc Natl Acad Sci U S A (1998) 1.34
Postexposure vaccination massively increases the prevalence of gamma-herpesvirus-specific CD8+ T cells but confers minimal survival advantage on CD4-deficient mice. Proc Natl Acad Sci U S A (2000) 1.34
Prolactin stimulation of maternal behavior in female rats. Science (1985) 1.34
Virus-specific memory T cells are Pgp-1+ and can be selectively activated with phorbol ester and calcium ionophore. Cell Immunol (1988) 1.33
Host response to Sendai virus in mice lacking class II major histocompatibility complex glycoproteins. J Virol (1995) 1.32
H-2 compatibility requirement for virus-specific T-cell-mediated cytolysis. Evaluation of the role of H-2I region and non-H-2 genes in regulating immune response. J Exp Med (1976) 1.30
The concept that surveillance of self is mediated via the same set of genes that determines recognition of allogenic cells. Cold Spring Harb Symp Quant Biol (1977) 1.29
Phenotypic analysis of the inflammatory exudate in murine lymphocytic choriomeningitis. J Exp Med (1987) 1.29
Bone marrow can function as a lymphoid organ during a primary immune response under conditions of disrupted lymphocyte trafficking. J Immunol (1997) 1.27
Different rules govern help for cytotoxic T cells and B cells. Nature (1979) 1.26
Suppression of cell-mediated immunity by street rabies virus. J Exp Med (1977) 1.25
Longitudinal analysis of the acute Sendai virus-specific CD4+ T cell response and memory. J Immunol (1998) 1.22
Secondary cytotoxic cell response to lymphocytic choriomeningitis virus II. Nature and specificity of effector cells. Immunology (1976) 1.21
Activation status of the CD4-8- gamma delta-T cells recovered from mice with influenza pneumonia. J Immunol (1991) 1.21
Prevalence and activation phenotype of Sendai virus-specific CD4+ T cells. Virology (1995) 1.21
Inhibition of autoimmune neuropathological process by treatment with an iron-chelating agent. J Exp Med (1984) 1.20
Mice lacking CD8+ T cells develop greater numbers of IgA-producing cells in response to a respiratory virus infection. Virology (1994) 1.17
Experimental louping-ill in sheep and lambs. I. Viraemia and the antibody response. J Comp Pathol (1971) 1.17
Induction of cytokines in mice with parainfluenza pneumonia. J Virol (1995) 1.15
Phenotypic and functional analysis of the cellular response in regional lymphoid tissue during an acute virus infection. J Immunol (1989) 1.15
Quantitative analysis of the acute and long-term CD4(+) T-cell response to a persistent gammaherpesvirus. J Virol (1999) 1.15
Influenzal pneumonia: early appearance of cross-reactive T cells in lungs of mice primed with heterologous type A viruses. Immunology (1978) 1.15
Divergence between cytotoxic effector function and tumor necrosis factor alpha production for inflammatory CD4+ T cells from mice with Sendai virus pneumonia. J Virol (1993) 1.13
Limiting dilution analysis of the specificity of influenza-immune cytotoxic T cells. Cell Immunol (1982) 1.12
Concurrent naive and memory CD8(+) T cell responses to an influenza A virus. J Immunol (2001) 1.12